Stay updated on Nivolumab in ER+ Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in ER+ Breast Cancer Clinical Trial page.

Latest updates to the Nivolumab in ER+ Breast Cancer Clinical Trial page
- ChecktodayChange DetectedThe page adds a recruitment status note and new guidance sections to help users join or understand the study, and updates the revision tag to v3.6.0 while adjusting the Intervention/Treatment heading.SummaryDifference0.1%

- Check8 days agoChange DetectedThe page now displays the latest revision label Revision: v3.5.5, replacing the previous v3.5.4. This indicates a minor update to the page versioning rather than a substantive content change.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedA new revision label v3.5.4 has been added, replacing the previous v3.5.3. This indicates an update to the page's revision history rather than any changes to the study content.SummaryDifference0.0%

- Check51 days agoChange DetectedThis change adjusts how the Chilean Valparaíso location is presented (e.g., region wording) while keeping the same city/address line for that site. It also reflects an automated site version/revision update without altering the study’s scientific or participant-relevant details.SummaryDifference0.2%

- Check58 days agoChange DetectedRevision: v3.5.2 was added and Revision: v3.5.0 was removed.SummaryDifference0.0%

- Check65 days agoChange DetectedAdded Padova, Italy 35128 and removed Padua, Italy 35128 from the study locations.SummaryDifference0.0%

Stay in the know with updates to Nivolumab in ER+ Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in ER+ Breast Cancer Clinical Trial page.